Immediate Impact
1 by Nobel laureates 1 from Science/Nature 58 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
Works of Erion Dobi being referenced
Second-line endocrine therapy (ET) with or without palbociclib (P) maintenance in patients (pts) with hormone receptor-positive (HR[+])/human epidermal growth factor receptor 2-negative (HER2[-]) advanced breast cancer (ABC): PALMIRA trial.
2023
Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Erion Dobi | 208 | 138 | 108 | 31 | 341 | |
| Laura Mansi | 218 | 88 | 77 | 29 | 352 | |
| Ajaz Bulbul | 165 | 195 | 75 | 19 | 331 | |
| Yu Li | 120 | 173 | 62 | 31 | 382 | |
| Corrado Gallo Stampino | 230 | 100 | 57 | 30 | 409 | |
| Eirini Thanopoulou | 143 | 148 | 107 | 25 | 370 | |
| Qing Zhang | 220 | 90 | 57 | 19 | 333 | |
| Erica Quaquarini | 219 | 148 | 88 | 32 | 357 | |
| V. Diéras | 257 | 63 | 82 | 25 | 317 | |
| Paule Augereau | 214 | 127 | 76 | 45 | 385 | |
| Yolanda Jerez | 283 | 80 | 96 | 30 | 407 |
All Works
Loading papers...